Employee Benefit Plans - Schedule of Stock Appreciation Rights - Stock Settled And Cash Settled Activity (Detail) - Stock Appreciation Rights - Stock Settled - USD ($) $ / shares in Units, $ in Millions |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Number of Stock Appreciation Rights | ||
| Shares outstanding, beginning (shares) | 3,493,312 | |
| Granted (shares) | 530,548 | |
| Exercised (shares) | (650,096) | |
| Canceled (shares) | (58,777) | |
| Shares outstanding, ending (shares) | 3,314,987 | |
| Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Grant Price [Abstract] | ||
| Outstanding, beginning balance (usd per share) | $ 157.58 | |
| Granted (usd per share) | 203.11 | |
| Exercised (usd per share) | 102.11 | |
| Canceled (usd per share) | 221.36 | |
| Outstanding, ending balance (usd per share) | $ 174.62 | |
| Aggregate Intrinsic Value | $ 179 | $ 175 |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments exercisable weighted average grant price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments forfeitures in period weighted average grant price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments grants in period weighted average grant price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average grant price. No definition available.
|
| X | ||||||||||
- Definition Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Grant Price No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|